For a long time, US Federal Reserve printed trillions of dollars to support the economy. But in the light of the highest inflation in almost 40 years, the stream of stimulus tends to shrink.
Pfizer, GM, AIG - what to expect?
2021-04-29 • Updated
Pfizer (reporting on May 4, 17:00 GMT+3)
Expected EPS: $0.79
This century-old pharma company gained global attention on vaccine production last autumn. At the peak of investor interest, it reached as high as $43 per share – heights unseen since the middle of 2019. Although the stock price was quick to cede the gains later on, it’s still in an uptrend. A positive Q1’2021 report may well push it to those heights again - fundamentally, there are all the reasons to expect strong performance.
Technically, if the report is better than the forecasts, the stock will likely rise to $41 and take $43 as a mid-term upside objective.
General Motors (reporting on May 5, 14:30 GMT+3)
Expected EPS: $1.01
This pillar of the US vehicle production industry not only managed to recover from the virus hit but reached strategically new highs of $60 – as high as never, at least over the course of the last ten years. The stock is now in a local drop so a strong report will push it back upwards to establish itself at new heights.
During the previous two quarters, GM managed to beat the expectations of observers brings better-than-thought results. In absolute figures, performance of Q1'2021 is expected to be lower than that of the second part of 2020. Hence, there is a big potential for GM to surprise the market and send the stock soar.
AIG (reporting on May 6, 15:30 GMT+3)
Expected EPS: $0.99
This financial and insurance corporation has not been doing well – it’s one of the companies that haven’t recovered the virus losses. Meeting March 2020 at the ranges of $50, this stock dropped as low as $20. Currently, it’s on the way upwards – right at the gates of the pre-virus level. Forecast-beating data will help it make a 100% recovery and move further upwards.
Last time, AIG's results were lower than the forecasts - that's one of the reason why observers are quite modest with their expectations this time. In the meantime, if AIG manages to outperform, that may be a real boost to its stock - tactically, it may aim at the pre-virus high of $56. That's only in case the data is exceptionally strong, though, which is not that likely. So, let's see the report out and watch the market reaction.
The major central banks will walk different paths in 2022. Some will respond to the threat of inflation, while others will continue to focus on boosting economic growth and recovering from the pandemic.
Find out if owning a Meta stock this year is a good idea
What is happening? The global energy crisis spreads around the globe…